Michael D Lockshin (Michael Lockshin)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Topics

Respiratory Syndrome Coronavirus

Aortic Dissection

Juvenile Idiopathic Arthritis

Top Venues

Arthritis & rheumatology (Hoboken, N.J.)

ACR open rheumatology

European journal of rheumatology

Clinical rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Medha Barbhaiya, Marianna B Frey, Jonah M Levine, Gregory J Vitone, Lindsay Lally, Michael D Lockshin, Vivian P Bykerk, Candace H Feldman, Lisa A Mandl
Modification of immunomodulatory medications by rheumatology patients during the peak of the COVID-19 pandemic in New York City. Clinical rheumatology 41 (8) (2022)
Xin Wang, Elena Gkrouzman, Danieli Castro de Oliveira Andrade, Laura Andreoli, Medha Barbhaiya, H Michael Belmont, David Ware Branch, Guilherme Ribeiro Ramires de Jésus, Maria Efthymiou, Roberto Ríos-Garcés, Maria Gerosa, Georges El Hasbani, Jason Knight, Pier Luigi Meroni, Giulia Pazzola, Michelle A Petri, Jacob Rand, Jane Salmon, Maria G G Tektonidou, Angela Tincani, Imad W Uthman, Stéphane Zuily, Yu Zuo, Michael D Lockshin, Hannah Cohen, Doruk Erkan, null null
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus 30 (14) (2021)
Medha Barbhaiya, Stephane Zuily, Yasaman Ahmadzadeh, Mary-Carmen Amigo, Tadej Avcin, Maria Laura Bertolaccini, D Ware Branch, Guilherme Ribeiro Ramires de Jésus, Katrien M J Devreese, Camille Frances, David Garcia, Francis Guillemin, Steven R Levine, Roger A Levy, Michael D Lockshin, Thomas L Ortel, Surya V Seshan, Maria Tektonidou, Denis Wahl, Rohan Willis, Ray Naden, Karen Costenbader, Doruk Erkan, null null
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis care & research 73 (10) (2021)
Michael D Lockshin, Mary K Crow, Medha Barbhaiya
When a Diagnosis Has No Name: Uncertainty and Opportunity. ACR open rheumatology (2021)
Elena Gkrouzman, Medha Barbhaiya, Doruk Erkan, Michael D Lockshin
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy. Arthritis & rheumatology (Hoboken, N.J.) 73 (1) (2020)
Michael D Lockshin
Differences between acute and chronic disease: comment on the article by Holman. ACR open rheumatology 2 (5) (2020)
Michael D Lockshin, Marta Guerra, Jane E Salmon
Elective Termination of Pregnancy in Autoimmune Rheumatic Diseases: Experience From Two Databases. Arthritis & rheumatology (Hoboken, N.J.) 72 (8) (2020)
Stéphane Zuily, Laurent Phialy, Ecem Sevim, Eloïse Germain, Ozan Unlu, Virginie Dufrost, Jessie Risse, Isabelle Clerc-Urmes, Cédric Baumann, Jessica R Berman, Michael D Lockshin, Denis Wahl, Doruk Erkan
Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study. European journal of rheumatology 6 (4) (2019)